AI assistant
Sending…
BIODESIX INC — Director's Dealing 2023
Apr 4, 2023
34472_dirs_2023-04-04_a86f3fe4-a2dc-459a-9889-af8c92469194.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2023-03-31
Reporting Person: Watts Charles M (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-31 | Common Stock | M | 150711 | — | Acquired | 202044 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | Restricted Stock Units | $ | M | 150711 | Disposed | Common Stock (150711) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
F2: These RSUs vested in full on March 31, 2023.
More from BIODESIX INC
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23